What is the official website of Fresenius Kabi Italia ?

The official website of Fresenius Kabi Italia is https://www.fresenius-kabi.com/it/.

What is Fresenius Kabi Italia's cybersecurity risk score?

Fresenius Kabi Italia has an AI-generated cybersecurity risk score of 753 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Fresenius Kabi Italia experienced?

According to Rankiteo, Fresenius Kabi Italia currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Fresenius Kabi Italia been affected by any supply chain cyber incidents ?

According to Rankiteo, Fresenius Kabi Italia has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Fresenius Kabi Italia have SOC 2 Type 1 certification ?

According to Rankiteo, Fresenius Kabi Italia is not certified under SOC 2 Type 1.

Does Fresenius Kabi Italia have SOC 2 Type 2 certification ?

According to Rankiteo, Fresenius Kabi Italia does not hold a SOC 2 Type 2 certification.

Does Fresenius Kabi Italia comply with GDPR ?

According to Rankiteo, Fresenius Kabi Italia is not listed as GDPR compliant.

Does Fresenius Kabi Italia have PCI DSS certification ?

According to Rankiteo, Fresenius Kabi Italia does not currently maintain PCI DSS compliance.

Does Fresenius Kabi Italia comply with HIPAA ?

According to Rankiteo, Fresenius Kabi Italia is not compliant with HIPAA regulations.

Does Fresenius Kabi Italia have ISO 27001 certification ?

According to Rankiteo,Fresenius Kabi Italia is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Fresenius Kabi Italia operate in ?

Fresenius Kabi Italia operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Fresenius Kabi Italia have ?

Fresenius Kabi Italia employs approximately 118 people worldwide.

Does Fresenius Kabi Italia own any subsidiaries ?

Fresenius Kabi Italia presently has no subsidiaries across any sectors.

How many LinkedIn followers does Fresenius Kabi Italia have ?

Fresenius Kabi Italia's official LinkedIn profile has approximately 4,059 followers.

What is the NAICS classification code for Fresenius Kabi Italia ?

Fresenius Kabi Italia is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Fresenius Kabi Italia have a Crunchbase profile ?

No, Fresenius Kabi Italia does not have a profile on Crunchbase.

Does Fresenius Kabi Italia have a LinkedIn profile ?

Yes, Fresenius Kabi Italia maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/fresenius-kabi-italia.

How many cybersecurity incidents has Fresenius Kabi Italia experienced ?

As of June 3, 2026, Rankiteo reports that Fresenius Kabi Italia has experienced 2 cybersecurity incidents.

How many peer or competitor companies does Fresenius Kabi Italia have ?

Fresenius Kabi Italia has an estimated 5,671 peer or competitor companies worldwide.

What types of cybersecurity incidents has Fresenius Kabi Italia faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Ransomware.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

FKI

Boost Score +25 with badge (5 left)

753

/1000

Fair

778

/1000

Fair

Fresenius Kabi Italia Vendor Cyber Rating & Cyber Score

fresenius-kabi.com

Add Your Compliance Badge

Fresenius Kabi è un'azienda farmaceutica operante a livello mondiale, specializzata in farmaci salvavita e tecnologie per infusione, trasfusione e nutrizione clinica. I prodotti e i servizi dell'azienda vengono impiegati per la terapia e la cura di pazienti critici e cronici. Il portfolio comprende una gamma di prodotti biofarmaceutici altamente complessi, nutrizione clinica, tecnologie mediche e farmaci generici per via endovenosa. Nell'ambito dei prodotti biofarmaceutici, Fresenius Kabi offre farmaci biosimilari con particolare attenzione alle malattie autoimmuni e all'oncologia; in quello della nutrizione clinica, dispone di un'ampia selezione di prodotti per la nutrizione enterale e parenterale. Nell’area delle tecnologie mediche,

FKI A.I CyberSecurity Scoring

Scoring History

FKI

Fresenius Kabi Italia CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

Fresenius Group

Ransomware

100

5/2020

FRE1770566194

Fresenius Kabi Ital...

Ransomware

05/2020

FRE2038291222

Loading…

A.I.

FKI Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for FKI

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Fresenius Kabi Italia in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Fresenius Kabi Italia in 2026.

Incident Types FKI vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Fresenius Kabi Italia in 2026.

Incident History - FKI (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Fresenius Kabi Italia Subsidiaries

FKI

Pharmaceutical Manufacturing

Website: https://www.fresenius-kabi.com/it/

Company Size: 118

Fresenius KabiPharmaceutical Manufacturing

Fresenius GroupHospitals and Health Care

Fresenius Digital TechnologyInformation Technology & Services

Fresenius Investor RelationsKrankenhäuser und Gesundheitseinrichtungen

Helios Health GmbHHospitals and Health Care

QuirónsaludWellness and Fitness Services

Helios Kliniken GmbHHospitals and Health Care

Fresenius Kabi BrasilPharmaceutical Manufacturing

Fresenius Kabi USAPharmaceutical Manufacturing

Fresenius Kabi FrancePharmaceutical Manufacturing

Fresenius Kabi CanadaPharmaceutical Manufacturing

Fresenius Kabi ArgentinaPharmaceutical Manufacturing

Fresenius Kabi Asia PacificPharmaceutical Manufacturing

Fresenius Kabi EspañaPharmaceutical Manufacturing

Fresenius Kabi MedTech EuropeMedical Equipment Manufacturing

Fenwal, Inc., a Fresenius Kabi CompanyMedical Equipment Manufacturing

Fresenius Kabi UKPharmaceutical Manufacturing

MOTIV eLearningHospitals and Health Care

Fresenius Kabi Australia and New ZealandPharmaceutical Manufacturing

Fresenius Kabi EcuadorPharmaceutical Manufacturing

Fresenius Kabi ColombiaPharmaceutical Manufacturing

Fresenius Kabi EuropePharmaceutical Manufacturing

Fresenius Kabi ChilePharmaceutical Manufacturing

Fresenius Kabi AustriaPharmaceutical Manufacturing

Fresenius Kabi Business ServicesAccounting

Fresenius Kabi PolskaPharmaceutical Manufacturing

Fresenius Kabi DanmarkPharmaceutical Manufacturing

Fresenius Kabi South AfricaPharmaceutical Manufacturing

Fresenius Kabi NetherlandsPharmaceutical Manufacturing

Fresenius Kabi IrelandPharmaceutical Manufacturing

Fresenius Kabi Viet Nam Pharmaceutical Manufacturing

Fresenius Kabi BelgiumPharmaceutical Manufacturing

Fresenius Kabi SchweizPharmaceutical Manufacturing

Fresenius Kabi (Singapore) Pte Ltd, SingaporePharmaceutical Manufacturing

Fresenius Kabi Puerto RicoManufacturing

Unidos por la Nutrición Clínica MéxicoHospitals and Health Care

Loading…

Fresenius Kabi Italia Similar Companies

Viatris

viatris.com

Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale. In 2022 alone, we supplied high-quality medicines to approximately 1 billion patients around the world. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world’s most enduring health challenges, access takes on deep meaning at Viatris. We have the ability to touch all of life’s moments, from birth to end of life, acute conditions to chronic diseases. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India Social Media Guidelines: https://newsroom.viatris.com/social-media-community-guidelines Investors: https://investor.viatris.com Corporate Social Responsibility: https://www.viatris.com/sustainability Connect with Viatris Instagram: https://www.instagram.com/viatrisinc X: https://www.x.com/viatrisinc Viatris and our recruiting firms will not ask for sensitive personal information, such as your social security number, date of birth or bank account details via text, email or social media. Additionally, Viatris representatives do not request payment or personal bank information nor send payment to purchase hardware on your own. Viatris.com is the primary source of all company job postings and authorized third-party career websites.

AUROBINDO PHARMA LTD

aurobindo.com

Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active pharmaceutical ingredients (APIs) across more than 150 countries. It is ranked among the top 10 generic companies in eight European nations and holds the distinction of being the largest generic pharmaceutical company in the United States. With over 30 state-of-the-art manufacturing and packaging facilities approved by leading global regulatory authorities including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA, Aurobindo Pharma ensures the highest standards of quality. Its robust portfolio spans eight major therapeutic areas: Central Nervous System (CNS), Antiretroviral (ARV), Cardiovascular (CVS), Antibiotics, Gastroenterology, Anti-diabetics, Oncology, and Dermatology, supported by a strong R&D infrastructure that drives innovation, affordability, and accessibility.

MANKIND PHARMA LTD

mankindpharma.com

Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating, developing, commercializing, and delivering affordable and accessible medicines that satisfy urgent medical needs. We take great pride in the success of our products ranging from Pharma, OTC and FMCG brands like Manforce Condoms, Manforce Tablets, Manforce Staylong Gel, Unwanted 72, Prega News, Gas-O-Fast, Kaloree 1, Kabzend, Acne Star Gel and many others. Our operations are in 34 overseas destinations across Asia, Africa, South-East Asia, Gulf countries and CIS countries. Our Vision - To be a global pharmaceutical company, most admired for its Affordability, Quality and Accessibility of products. Our Mission - To be able to provide cost-effective, innovation based superior quality pharmaceutical products across the globe, to improve the lives of the patients. Mankind strongly believes and follows its Core Values: 𝐂𝐮𝐬𝐭𝐨𝐦𝐞𝐫 𝐂𝐞𝐧𝐭𝐫𝐢𝐜𝐢𝐭𝐲: Commitment to Customer - Internal and External 𝐐𝐮𝐚𝐥𝐢𝐭𝐲: It is in our DNA to maintain and deliver highest quality standards and products 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧: Intensely Research driven organization aiming at product innovation and technology improvements 𝐈𝐧𝐭𝐞𝐠𝐫𝐢𝐭𝐲: Always trustworthy, widely respected to be honest, and believed by everyone 𝐆𝐨 𝐁𝐞𝐲𝐨𝐧𝐝: Aim higher than capabilities 𝐏𝐞𝐨𝐩𝐥𝐞 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧: Together we are foreseeing future and diligently stimulating our people in attaining goals

Zydus Group

zyduslife.com

The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global life-sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs over 27000 people worldwide and is driven by its mission to unlock new possibilities in life-sciences through quality healthcare solutions that impact lives. The group aspires to transform lives through pathbreaking discoveries.

Hikma Pharmaceuticals

cb hikma.com

For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists need to treat their patients across North America, MENA and Europe. We have 29 manufacturing plants, 3 R&D hubs and c9,500 employees worldwide. *As of December 2025 Subscribe to our channel on YouTube https://youtube.com/@hikmapharmaceuticals5668 For all product information and enquiries, please contact us at [email protected]

Alembic Pharmaceuticals Limited

alembic-india.com

Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrolides segment of anti-infective drugs in India. Alembic's manufacturing facilities are located in Vadodara and Baddi in Himachal Pradesh. The plant at Vadodara has the largest fermentation capacity in India. The Panelav facility houses the API and formulation manufacturing (both US FDA approved) plants. The plant at Baddi, Himachal Pradesh manufactures formulations for the domestic and non-regulated export market. The company has a state of the art Research Centre at Vadodara.

Sandoz

sandoz.com

Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health challenges such as antimicrobial resistance. We are present in more than 100 countries and our medicines serve some 500 million people every year. We have two main global businesses: Generics - divided between standard generics and complex generics - and Biosimilars. Read our community engagement guidelines: http://bit.ly/4ofoggc

Catalent

catalent.com

Championing the missions that matter™. Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) and trusted partner to pharma, biotech, and consumer health companies worldwide. We put patients first in everything we do, helping people live better and healthier lives through every product we help develop, manufacture and deliver. With over 1,000 active development programs at any given time, we launch over 100 new products and line extensions annually. Catalent has supported half of all FDA approvals over the past decade, and our teams working at over 40 global sites help us produce over 60 billion doses every year. Our strength lies in our people: teams across our more than 40 sites and thousands of passionate scientists and technicians who bring expertise in development sciences, delivery technologies, and multi-modality manufacturing. What unites us is our commitment to championing our partners’ missions as our own, anticipating customer needs, solving complex challenges and ultimately making a difference in the lives of patients across the globe. At Catalent, you will be able to directly have an impact, solving problems and ensuring excellence for our customers. Our focus on delivering meaningful outcomes alongside our customers means your work directly impacts millions of people around the world. Join us in championing the missions that matter. Catalent is headquartered in Tampa, Florida, with over 40 global sites. Visit www.catalent.com to learn more.

UCB

cb ucb.com

At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease. Our purpose is to support people living with severe central nervous system and immunological conditions by delivering meaningful solutions that go beyond medicine. We are driven by the experiences of patients and caregivers, and inspired to pursue innovations that create real value - not just in clinical outcomes, but in everyday moments, dreams pursued, and simple pleasures enjoyed. Our ambition is to unlock transformative science and technologies that respond to unmet needs and elevate lives. From our headquarters in Belgium to nearly 40 countries around the world, we nurture a culture of respect and care. By listening deeply and collaborating across borders and disciplines, we enable cutting-edge research shaped by patients’ needs. Through strong connections with healthcare professionals, partners, and communities, we strive to make a lasting impact - today and into the future. We're inspired by patients, driven by science.

Loading…

NEWS

Fresenius Kabi Italia CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

December 22, 2021 08:00 AM

FDA, CISA Warn of Fresenius Kabi Infusion Pump Flaws

US government authorities have issued an advisory warning about remotely exploitable security vulnerabilities in certain Fresenius Kabi infusion pump systems.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-44654

SUMMARY

LibreChat is an enhanced ChatGPT clone that supports multiple AI providers. In versions up to and including 0.8.3, a shared-agent editor can delete file records through `DELETE /api/files` that the owner has reused across multiple agents. The deletion removes the file globally — not just from the shared agent — breaking the owner's other private agents that reference the same `file_id`. The private agent retains a stale `file_id` reference that no longer resolves. A shared-agent editor can destroy files that the owner uses across multiple agents. The owner's private agents — which the attacker has no access to — break silently with stale `file_id` references. This is a cross-agent integrity violation: editing access to one agent should not affect another. Version 0.8.4 contains a patch.

Published

Date2026-06-02

Updated

Date2026-06-02

RISK INFORMATION (Score: )

cvss4

Base Score: 5.7

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:H/VA:H/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

https://github.com/danny-avila/LibreChat/security/advisories/GHSA-f8jg-v856-mf6q

CVE-2026-44653

SUMMARY

LibreChat is an enhanced ChatGPT clone that supports multiple AI providers. In versions up to and including 0.8.3, users with only `VIEW` access to an MCP server can retrieve the server's decrypted admin-managed secrets through `GET /api/mcp/servers` and `GET /api/mcp/servers/:serverName`. The returned config includes plaintext values for `apiKey.key` and `oauth.client_secret`. This allows viewers of a shared MCP server to exfiltrate the underlying provider credentials. Version 0.8..4 contains a patch. Other remediations include: never returning decrypted admin-managed secrets to non-owners; redacting apiKey.key and oauth.client_secret from all API responses consider returning only boolean presence indicators for secrets, similar to the auth-values route pattern; and, if owners need to edit configs without re-entering secrets, preserving secrets server-side and returning placeholders instead of plaintext.

Published

Date2026-06-02

Updated

Date2026-06-02

RISK INFORMATION (Score: 6.5)

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N

Impact Score

3.6

Exploitability

2.8

REFERENCES

https://github.com/danny-avila/LibreChat/security/advisories/GHSA-6vqg-rgpm-qvf9

CVE-2026-42507

SUMMARY

When returning errors, functions in the net/textproto package would include its input as part of the error. This might allow an attacker to inject misleading content to errors that are printed or logged.

Published

Date2026-06-02

Updated

Date2026-06-02

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

CVE-2026-42504

SUMMARY

Decoding a maliciously-crafted MIME header containing many invalid encoded-words can consume excessive CPU.

Published

Date2026-06-02

Updated

Date2026-06-02

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

CVE-2026-41412

SUMMARY

alf.io is an open source ticket reservation system for conferences, trade shows, workshops, and meetups. Prior to version 2.0-M5-2606, the alf.io extension sandbox injects a fully-functional HTTP client (`simpleHttpClient`) into every extension script's scope. The `postFileAndSaveResponse()` method accepts an arbitrary filesystem path as its `file` parameter and reads the file contents using `new FileInputStream(file)` with no path validation, directory restriction, or allowlist. A malicious extension script can read any file accessible to the JVM process user and exfiltrate it to an attacker-controlled server via HTTP POST. Version 2.0-M5-2606 patches the issue.

Published

Date2026-06-02

Updated

Date2026-06-02

RISK INFORMATION (Score: 4.9)

cvss3

Base Score: 4.9

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:N/A:N

Impact Score

3.6

Exploitability

1.2

REFERENCES

https://github.com/alfio-event/alf.io/security/advisories/GHSA-6m62-53cw-4373

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…